Comparison of the ischemic and non-ischemic lung cancer metabolome reveals hyper activity of the TCA cycle and autophagy.
Comparison of the ischemic and non-ischemic lung cancer metabolome reveals hyper activity of the TCA cycle and autophagy.
复制标题
DOI:
10.1016/j.bbrc.2020.07.082
复制
发表时间:
2020-09
影响因子:
3.1
通讯作者:
N. Kikuchi;T. Soga;Miyuki Nomura;Taku Sato;Yoshimi Sakamoto;R. Tanaka;Jiro Abe;Mami Morita;H. Shima;Y. Okada;N. Tanuma
中科院分区:
文献类型:
--
作者:
N. Kikuchi;T. Soga;Miyuki Nomura;Taku Sato;Yoshimi Sakamoto;R. Tanaka;Jiro Abe;Mami Morita;H. Shima;Y. Okada;N. Tanuma
Recent advances in cancer biology reveal the importance of metabolic changes in cancer; however, less is known about how metabolic pathways in tumors are regulatedin vivo. Here, we report analysis of the lung cancer metabolism based on different surgical procedures, namely lobectomy and partial resection. In lobectomy, but not in partial resection, pulmonary arteries and veins are ligated prior to removal of tissues, rendering tissues ischemic. We show that tumors indeed undergo ischemia upon lobectomy and that the tumor metabolome differs markedly from that of tumors removed by partial resection. Comparison of the responses to ischemia in tumor and normal lung tissues revealed that lung cancer tissue exhibits greater TCA cycle and autophagic activity than do normal lung tissuesin vivoin patients. Finally, we report that deletingATG7, which encodes a protein essential for autophagy, antagonizes growth of tumors derived from lung cancer cell lines, suggesting that autophagy confers metabolic advantages to lung cancer. Our findings shed light on divergent metabolic responses to ischemia seen in tumors and normal tissues.